Evidence map›Paper›PMID 22431994›Full record

ArticlePloS one2012

Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.

Ivano de Filippis, Ana Paula S de Lemos, Jessica B Hostetler, Kurt Wollenberg, Claudio T Sacchi, Julie C Dunning Hotopp, Lee H Harrison, Margaret C Bash, D Rebecca Prevots

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Ongoing Outbreak ofOpen forum infectious diseases · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

  • Erratum issued
    Dunning Hotopp, Julie C [added]
5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Ivano de FilippisNational Quality Control Institute (INCQS), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Ana Paula S de Lemos
Jessica B Hostetler
Kurt Wollenberg
Claudio T Sacchi
Julie C Dunning Hotopp
Lee H Harrison
Margaret C Bash
D Rebecca Prevots
Instituto Adolfo Lutz · BRNational Institute of Allergy and Infectious Diseases · USCenter for Biologics Evaluation and Research · USJ. Craig Venter Institute · USNational Institutes of Health · USUniversity of Pittsburgh · US

Funding

Real-Time PCR for Diagnosis of Culture-Negative Bacterial Meningitis in S?o PauloD43TW006592 · FIC · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HARRISON, LEE H · 2004 to 2013
$1.7M
Shedding of HIV In Semen Despite Antiretroviral TherapyK24AI052788 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HARRISON, LEE H · 2002 to 2012
$1.4M
Molecular Epidemiology of Bacteria and VirusesZIAAI001036 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI PREVOTS, D · 2009 to 2012
$987k
FIC NIH HHS D43 TW006592FIC NIH HHS D43TW006592Intramural NIH HHSNIAID NIH HHS K24 AI052788NIAID NIH HHS K24 AI52788NIAID NIH HHS N01 AI030071NIAID NIH HHS N01-AI30071
6 · The paper itself

Abstract

backgroundNeisseria meningitidis serogroup B has been predominant in Brazil, but no broadly effective vaccine is available to prevent endemic meningococcal disease. To understand genetic diversity among serogroup B strains in Brazil, we selected a nationally representative sample of clinical disease isolates from 2004, and a temporally representative sample for the state of São Paulo (1988-2006) for study (n = 372).

methodsWe performed multi-locus sequence typing (MLST) and sequence analysis of five outer membrane protein (OMP) genes, including novel vaccine targets fHbp and nadA.

resultsIn 2004, strain B:4:P1.15,19 clonal complex ST-32/ET-5 (cc32) predominated throughout Brazil; regional variation in MLST sequence type (ST), fetA, and porB was significant but diversity was limited for nadA and fHbp. Between 1988 and 1996, the São Paulo isolates shifted from clonal complex ST-41/44/Lineage 3 (cc41/44) to cc32. OMP variation was associated with but not predicted by cc or ST. Overall, fHbp variant 1/subfamily B was present in 80% of isolates and showed little diversity. The majority of nadA were similar to reference allele 1.

conclusionsA predominant serogroup B lineage has circulated in Brazil for over a decade with significant regional and temporal diversity in ST, fetA, and porB, but not in nadA and fHbp.

Indexed as

Bacterial Typing TechniquesBase SequenceBiodiversityBrazilGenes, BacterialGenetic VariationGeographyHumansLikelihood FunctionsMeningococcal InfectionsMolecular EpidemiologyMolecular Sequence DataMultilocus Sequence TypingNeisseria meningitidis, Serogroup BPhylogenyTime Factors

Identifiers

PMID22431994
PMCPMC3303791
OpenAlexW2110075996

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.